Publications by authors named "Mebie Singo"
Article Synopsis
- The study focuses on short- and long-term antibody responses to pneumococcal vaccines in HIV-infected adults, comparing two types of vaccines: Pneumovax-23 (PPV) and Prevenar-13 (PCV).
- A subgroup of 152 participants from a larger study had their antibody levels measured before and after vaccination, with ongoing assessments for four years. Results indicated that those vaccinated with PCV had a higher likelihood of achieving the World Health Organization's antibody threshold than those who received PPV.
- Specifically, 54% of PCV recipients reached the target after one dose compared to 33% with PPV, and this advantage continued with booster doses, showing better cumulative rates
Measurement of HIV viral load (VL) is the best indicator of success of antiretroviral therapy. We investigated the correlation between results by the Cepheid GeneXpert and a standard of care VL assay (Abbott M2000). This was a prospective study of people living with HIV who attended the department for routine VL measurement with the Abbott M2000.
View Article and Find Full Text PDFU.K. guidelines for vaccinating HIV-infected adults against bacteria are based on limited data.
View Article and Find Full Text PDF